Cholinesterase inhibitors (also called acetylcholinesterase inhibitors) are a group of medicines that block the normal breakdown of acetylcholine. Acetylcholine is the main neurotransmitter found in the body and has functions in both the peripheral nervous system and the central nervous system. For example, acetylcholine is released by motor neurons to activate muscles; acetylcholine also has an important role in arousal, attention, learning, memory and motivation.

Cholinesterase inhibitors block the action of the enzyme cholinesterase, which is responsible for breaking down acetylcholine. This increases levels of acetylcholine in the synaptic cleft (the space between two nerve endings).

The main use of cholinesterase inhibitors is for the treatment of dementia in patients with Alzheimer's disease. People with Alzheimer's disease have reduced levels of acetylcholine in the brain. Cholinesterase inhibitors have been shown to have a modest effect on dementia symptoms such as cognition.

Market Analysis and Insights: Global Cholinesterase Inhibitors Market
The global Cholinesterase Inhibitors market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.

Global Cholinesterase Inhibitors Scope and Market Size
The global Cholinesterase Inhibitors market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cholinesterase Inhibitors market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
Haboyin
Tacrine
Donepezil
Rivastigmine
Galantamine
Others

Segment by Application
Mild Patient
Moderate Patient
Serious Patient

The Cholinesterase Inhibitors market is analysed and market size information is provided by regions (countries). Segment by Application, the Cholinesterase Inhibitors market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
Pfizer
Shionogi Pharma
Daiichi Pharmaceutical Co Ltd
Novartis
F. Hoffmann-La Roche
Merck
Eli Lily & Co
Taloph pharmaceutical
Forward group
Eisai Co., Ltd
ACI HealthCare Limited
Actavis Elizabeth LLC
Alembic pharms Ltd
Aurobindo
Cadila pharms Ltd
Cipla Ltd
CSPC Ouyi
Dexcel pharma
Dr.Reddy's
Heritage Pharma
Hetero Labs Ltd
Indicus Pharma